IDH1 and neoplasm: In addition to insulin-signaling-related mechanisms that mediate tumor growth and survival [78], a link between epigenetics and cell metabolism exists and is best highlighted by IDH1 mutations (see Section 2.2), which likely impact metabolism via altered metabolic flux of α-ketogluterate and NAPDH, thereby impairing normal biosynthetic pathways [79,80].